DR. LARRY MARK WEISENTHAL, MD., PHD.
Osteopathic Medicine at Burke Ln, Huntington Beach, CA
License number
California 66724
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
16512 Burke Ln, Huntington Beach, CA 92647
Phone
(714) 596-2100
(714) 596-2110 (Fax)
(714) 596-2110 (Fax)
Professional information
Dr. Larry M Weisenthal - MD (Doctor of Medicine)
Hospitals:
Weisenthal Cancer Group
16512 Burke Ln, Huntington Beach 92647
Orange Coast Memorial Medical Center
9920 Talbert Ave, Fountain Valley 92708
Weisenthal Cancer Group
16512 Burke Ln, Huntington Beach 92647
Orange Coast Memorial Medical Center
9920 Talbert Ave, Fountain Valley 92708
16512 Burke Ln, Huntington Beach 92647
Orange Coast Memorial Medical Center
9920 Talbert Ave, Fountain Valley 92708
Weisenthal Cancer Group
16512 Burke Ln, Huntington Beach 92647
Orange Coast Memorial Medical Center
9920 Talbert Ave, Fountain Valley 92708
Education:
Medical Schools
University of Mi Med Sch
Graduated: 1975
University of Mi Med Sch
Graduated: 1975
Efficient Well Being Assessment And Improved Treatment Protocol
US Patent:
8278033, Oct 2, 2012
Filed:
May 22, 2009
Appl. No.:
12/994105
Inventors:
Larry Mark Weisenthal - Huntington Beach CA, US
International Classification:
G01N 33/53
US Classification:
435 4, 436518
Abstract:
Methods to appraise general health and to assess the effectiveness of therapeutic agents are disclosed. These methods can be performed on blood samples or other bodily fluids and comprise effecting cell death of endothelial cells, staining the dead cells and observing them microscopically. In addition, the invention is directed to combination treatments for neoplastic diseases or other conditions characterized by unwanted angiogenesis by administering an antiangiogenesis agent while maintaining nontoxic levels of ethanol and/or DMSO in the blood.
Method To Detect Endothelial Cell Massive Calcium Accumulation Death
US Patent:
8623613, Jan 7, 2014
Filed:
Apr 13, 2011
Appl. No.:
13/085856
Inventors:
Larry M. Weisenthal - Huntington Beach CA, US
International Classification:
C12Q 1/06, C12Q 1/04, G01N 1/30, G01N 33/48
US Classification:
435 39, 435 405, 435 34
Abstract:
Stains that are specific for calcium ion are used to assess and predict the effects of various treatments on the viability of cell types contained in a sample, wherein said stain detects endothelial cells that have massive calcium accumulation death.
Method For Detecting Immune-Mediated Cytotoxicity
US Patent:
4996145, Feb 26, 1991
Filed:
Oct 27, 1987
Appl. No.:
7/114085
Inventors:
Larry M. Weisenthal - Huntington Beach CA
Assignee:
Oncotech Incorporated - Irvine CA
International Classification:
G01N 3353, G01N 33577, C12Q 128, C12Q 118
US Classification:
435 723
Abstract:
A method for detecting the sensitivity of tumor cells to immune effector substances by using an assay that distinguishes living tumor cells from dead cells in mixed populations of cells. Acquired resistance to immune effectors used in therapy may be determined and used to identify methods to circumvent such resistance using the method.
Immunopotentiating Protocol For Chemotherapy-Responsive Tumors
US Patent:
5149527, Sep 22, 1992
Filed:
Sep 18, 1990
Appl. No.:
7/584272
Inventors:
Larry M. Weisenthal - Huntington Beach CA
Assignee:
Oncotech, Inc. - Irvine CA
International Classification:
A61K 3702
US Classification:
424 852
Abstract:
Immunopotentiating compositions which are useful in causing tumor necrosis and/or regression in subjects who have previously received successful therapy which destroys tumors and stimulates cytotoxic macrophages are described. The immunopotentiators are administered at a time when formation of macrophages specifically cytotoxic for the tumor have been generated by previous therapy.
Microaggregates Including Endothelial Cells
US Patent:
8192949, Jun 5, 2012
Filed:
Dec 15, 2006
Appl. No.:
11/639873
Inventors:
Larry M. Weisenthal - Huntington Beach CA, US
International Classification:
G01N 1/28, G01N 1/30, C12Q 1/00
US Classification:
435 405, 435 4, 435 29
Abstract:
Microaggregates which mimic the native environment of cells contained in biopsied tissue are used to assess and predict the effects of various treatments on the viability of cell types contained in the microaggregate.
Treatment Protocol
US Patent:
2013001, Jan 10, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/620081
Inventors:
Larry Mark WEISENTHAL - Huntington Beach CA, US
International Classification:
A61K 31/045, A61K 31/10, A61P 9/00, A61K 39/395
US Classification:
4241331, 514724, 514708
Abstract:
Combination treatments with an antiangiogenesis agent and non-toxic blood levels of ethanol and/or DMSO are disclosed.
Osteopathic Medicine licenses in California
YASSER H. SALEM MD., PROFESSIONAL CORPORATION, , 8101 Newman Ave SUITE D, Huntington Beach, CA 92647